The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?

por Baker, Stuart G, Kramer, Barnett S
Publicado 2002

Identifying genes that contribute most to good classification in microarrays

por Baker, Stuart G, Kramer, Barnett S
Publicado 2006

Randomized trials, generalizability, and meta-analysis: Graphical insights for binary outcomes

por Baker, Stuart G, Kramer, Barnett S
Publicado 2003

Paradoxes in carcinogenesis: New opportunities for research directions

por Baker, Stuart G, Kramer, Barnett S
Publicado 2007

A perfect correlate does not a surrogate make

por Baker, Stuart G, Kramer, Barnett S
Publicado 2003

Correction: The transitive fallacy for randomized trials: If A bests B and B bests C in separate trials, is A better than C?

por Baker, Stuart G, Kramer, Barnett S
Publicado 2003

Simple Methods for Evaluating 4 Types of Biomarkers: Surrogate Endpoint, Prognostic, Predictive, and Cancer Screening

por Baker, Stuart G, Kramer, Barnett S
Publicado 2020

Markers for early detection of cancer: Statistical guidelines for nested case-control studies

por Baker, Stuart G, Kramer, Barnett S, Srivastava, Sudhir
Publicado 2002

Estimating the cumulative risk of false positive cancer screenings

por Baker, Stuart G, Erwin, Diane, Kramer, Barnett S
Publicado 2003

The fallacy of enrolling only high-risk subjects in cancer prevention trials: Is there a "free lunch"?

por Baker, Stuart G, Kramer, Barnett S, Corle, Donald
Publicado 2004

The Paired Availability Design for Historical Controls

por Baker, Stuart G, Lindeman, Karen S, Kramer, Barnett S
Publicado 2001

Statistical issues in randomized trials of cancer screening

por Baker, Stuart G, Kramer, Barnett S, Prorok, Philip C
Publicado 2002

Development Tracks for Cancer Prevention Markers

por Baker, Stuart G., Kramer, Barnett S., Prorok, Philip C.
Publicado 2004

Using observational data to estimate an upper bound on the reduction in cancer mortality due to periodic screening

por Baker, Stuart G, Erwin, Diane, Kramer, Barnett S, Prorok, Philip C
Publicado 2003

Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST)

por Kramer, Barnett S, Berg, Christine D, Aberle, Denise R, Prorok, Philip C
Publicado 2011

Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats

por Baker, Stuart G, Soto, Ana M, Sonnenschein, Carlos, Cappuccio, Antonio, Potter, John D, Kramer, Barnett S
Publicado 2009

Resisting recommended treatment for prostate cancer: a qualitative analysis of the lived experience of possible overdiagnosis

por McCaffery, Kirsten, Nickel, Brooke, Pickles, Kristen, Moynihan, Ray, Kramer, Barnett, Barratt, Alexandra, Hersch, Jolyn
Publicado 2019

Biomedical research and dissemination: The value of global collaborations

por Kramer, Barnett S., Dai, Min, Beckwith, Margaret, Hu, Ping, Li, Ni, Ren, Jiansong, Taylor, Martina, He, Jie
Publicado 2021

Cancer screening in China: a steep road from evidence to implementation

por Xia, Changfa, Basu, Partha, Kramer, Barnett S, Li, He, Qu, Chunfeng, Yu, Xue Qin, Canfell, Karen, Qiao, Youlin, Armstrong, Bruce K, Chen, Wanqing
Publicado 2023

Getting It Right: Being Smarter about Clinical Trials

por Kramer, Barnett S, Wilentz, Joan, Alexander, Duane, Burklow, John, Friedman, Lawrence M, Hodes, Richard, Kirschstein, Ruth, Patterson, Amy, Rodgers, Griffin, Straus, Stephen E
Publicado 2006